The clinical relevance of ELK3 protein abundance in PCa tissues was confirmed by an IHC assay using an ELK3-specific antibody in PCa patients (n = 117, Supplementary Fig. S5). This evidence concerns the gene ELK3 and posterior cortical atrophy.